Exact Sciences
EXAS
#1156
Rank
โ‚ฌ16.40 B
Marketcap
86,45ย โ‚ฌ
Share price
0.00%
Change (1 day)
47.86%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -โ‚ฌ0.93 Billion

According to Exact Sciences's latest financial reports the company's current earnings are โ‚ฌ3.08 Billion. In 2024 the company made an earning of -โ‚ฌ0.87 Billion a decrease over its 2023 earnings that were of -โ‚ฌ0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.93 Billion7%
2024 -โ‚ฌ0.87 Billion435.05%
2023 -โ‚ฌ0.17 Billion-69.18%
2022 -โ‚ฌ0.53 Billion-25.77%
2021 -โ‚ฌ0.71 Billion1.68%
2020 -โ‚ฌ0.7 Billion271.17%
2019 -โ‚ฌ0.19 Billion58.99%
2018 -โ‚ฌ0.12 Billion20.89%
2017 -โ‚ฌ97.66 Million-30.95%
2016 -โ‚ฌ0.15 Billion5.09%
2015 -โ‚ฌ0.14 Billion57.24%
2014 -โ‚ฌ85.59 Million116.53%
2013 -โ‚ฌ39.53 Million
2011 -โ‚ฌ24.61 Million143.73%
2010 -โ‚ฌ10.1 Million27.85%
2009 -โ‚ฌ7.9 Million0.27%
2008 -โ‚ฌ7.88 Million-20.95%
2007 -โ‚ฌ9.97 Million-13.53%
2006 -โ‚ฌ11.53 Million-10.07%
2005 -โ‚ฌ12.82 Million-21.81%
2004 -โ‚ฌ16.39 Million-33.44%
2003 -โ‚ฌ24.63 Million-6.51%
2002 -โ‚ฌ26.34 Million17.95%
2001 -โ‚ฌ22.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Myriad Genetics
MYGN
-โ‚ฌ0.36 Billion-56.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
โ‚ฌ56.25 M-106.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
โ‚ฌ21.12 M-102.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-โ‚ฌ29.86 Million-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.76 B-1,038.16%๐Ÿ‡ซ๐Ÿ‡ท France